MedicineChemistry

A. Yapi, A. Valentin, J. Chezal, O. Chavignon, B. Chaillot, Roseline Gerhardt, J. Teulade, Y. Blache

2006.4.1ARCHIV DER PHARMAZIE

DOI: 10.1002/ardp.200500246

tlooto Summary

A series of trisubstituted 1,10‐phenanthrolines was prepared and one compound exhibited a selective activity against malaria parasite and antiplasmodial activity of this derivative was optimized by N‐10 alkylation and the phenanthrolinium salt.

Abstract

A series of trisubstituted 1,10‐phenanthrolines was prepared. These compounds exhibited mild to high biological activities in vitro both toward chloroquino‐resistant FcB1‐Columbia and FcM29‐Cameron strains and Nigerian chloroquino‐sensitive strain of Plasmodium falciparum . Cytotoxicity of the most active compounds was estimated showing that one compound ( 10 ) exhibited a selective activity against malaria parasite (selectivity indexes of 52 and 144). Antiplasmodial activity of this derivative was optimized by N ‐10 alkylation and the phenanthrolinium salt ( 15 ) submitted to an in vivo study using mices infected by P. vinckei petteri showing an ED 50 of 7.86 mg/kg/day.

Citation format

YAPI, A., et al. In vitro and in vivo antimalarial activity of derivatives of 1,10‐phenanthroline framework. ARCHIV DER PHARMAZIE, 2006, 339.